Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
MicuRx Pharmaceuticals, Inc.
4366
MicuRx Pharmaceuticals, Inc.
Health Care
Technology
Biotechnology
Medical
Pharmaceuticals
MicuRx is a clinicalstage biopharmaceutical company developing innovative antibiotics for multidrugresistant (MDR) bacterial infections including MRSA and VRE..
Suggest edits
Type
B2b
Founded
2007
Raised
$133M
Follow us
Companies in the same industry
Ritter Pharmaceuticals, Inc.
SkyQuest Technology Consulting Private Limited
Strongbridge Biopharma
Aratana Therapeutics
Hyasynth Bio
Bioquark Inc.
CANbridge Life Sciences Ltd.
Sensulin
Neurogastrx
Ultragenyx Pharmaceutical
Alexa global traffic share
Overview
Funding
4
Add info
Latest funding
Show all
$43,000,000
Venture capital (Series D) - 2020
Huagai Capital
Zero2IPO Asset Management
Sinopharm-CICC Medical & Healthcare Investment Management
$55,000,000
Venture capital (Series C) - 2016
GP Healthcare Capital
GP TMT Capital
3E Bioventures Capital
+3
Team Size
10+
Employees
I work here
Location
United States
Headquarters
Explore United States
$43,000,000
Venture capital (Series D)
AVCJ
Huagai leads $43m round for China antibiotics developer
ChinaMoneyNetwork
HG Capital Leads Series D Round In MicuRx Pharmaceuticals – China Money Network
$55,000,000
Venture capital (Series C)
yahoo
,
FinSMEs
,
prnasia
MicuRx Closes $55 Million Series C Financing to Support Development of Next-Generation Antibiotic MRX-I
Health
